Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes
Authors:
- 2 October 2001
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (21) , 12168-12173
Abstract
The invariant chain (Ii) binds to newly synthesized MHC class II molecules with the CLIP region of Ii occupying the peptide-binding groove. Here we demonstrate that recombinant Ii proteins with the CLIP region replaced by antigenic self-epitopes are highly efficient in activating and silencing specific T cellsin vitroandin vivo. The Ii proteins require endogenous processing by antigen-presenting cells for efficient T cell activation. An Ii protein encompassing the epitope myelin basic protein amino acids 84–96 (Ii-MBP84–96) induced the model autoimmune disease experimental allergic encephalomyelitis (EAE) with a higher severity and earlier onset than the peptide. When applied in a tolerogenic manner, Ii-MBP84–96 abolished antigen-specific T cell proliferation and suppressed peptide-induced EAE more effectively than peptide alone. Importantly, i.v. administration of Ii proteins after EAE induction completely abrogated the disease, whereas peptides only marginally suppressed disease symptoms. Ii fusion proteins are thus more efficient than peptide in modulating CD4+T cell-mediated autoimmunity, documenting their superior qualities for therapeutic antigen deliveryin vivo.Keywords
This publication has 21 references indexed in Scilit:
- The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3Nature, 1995
- Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.Proceedings of the National Academy of Sciences, 1995
- Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.Journal of Experimental Medicine, 1995
- In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptidesImmunity, 1994
- Mapping functional regions in the lumenal domain of the class II-associated invariant chain.Journal of Experimental Medicine, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides.Proceedings of the National Academy of Sciences, 1993
- Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple SclerosisScience, 1993
- Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced AnergyScience, 1992
- Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic proteinJournal of Neuroimmunology, 1988